pulmonary embolism

Birth Control Induced Pulmonary Emboli: Sudden and Slow

8705 views

Pulmonary emboli are notoriously difficult to diagnose clinically, especially in otherwise healthy young women. The early signs include such nondescript symptoms as breathing difficulties, chest or back pain, and fatigue; symptoms that are easily attributable to a host of viral and bacterial infections or other less serious respiratory conditions. As a result, and more often than not, it is not until complete hemodynamic collapse that PE is considered; a point at which survival is significantly less likely. Even then, for young women the prospect of pulmonary emboli is not always on the differential. We saw this repeatedly in our pilot study, the Real Risk Birth Control and Blood Clots study where the prospect of birth control induced blood clots was rarely considered. From a review of records and case stories, blood clots seemed only to be considered after everything else was ruled out. That is, they were near the bottom, if not absolutely last, on the diagnostic differential. When the emboli were in the lungs, this refusal to consider contraceptive induced hyper-coagulation has deadly consequences.

When we consider that the most commonly recognized risk associated with hormonal birth control are blood clots, one cannot help but wonder why birth control-induced blood clots are not automatically ruled out when women present to the ER in crisis, but they are not. Time and time again, the early signs of an imminent crisis were dismissed by healthcare practitioners. Neither the deep vein thrombi that frequently preceded the pulmonary emboli by as much as a month, nor the pulmonary emboli were immediately recognized. And as we reported previously, recognition was equally labored in women who developed cerebral venous thrombi, brain clots, often requiring 2-3 ER visits before the diagnosis is even considered. I am not sure why there is such a total break down in clinical acuity when it comes to birth control-induced blood clots, but by all accounts, there is.

Perhaps our familiarity with these drugs has bred a false sense of safety; one so firmly entrenched that even when faced with evidence to the contrary, when life or death hang in balance, we cannot bring ourselves to acknowledge their risks. Perhaps so strong is our desire and need to have effective birth control options, that we employ a sort of willful ignorance about the risks. Or more cynically, perhaps we have simply been duped by Madmen inspired, pharmaceutical funded half-truths and platitudes.

Whatever the reasons, the patient reports suggest that when confronted with evidence of blood clots, all involved tend to dismiss the possibility until all other causes are ruled out. Physicians especially seem reticent to consider blood clots, forgetting entirely that hormonal birth control hyperactivates blood coagulation cascades in favor of clotting – in all women, not just some women, but in all women. They increase pro-clotting factors by 170% and decrease anti-clotting factors by 20%, a change in hemodynamics that all but guarantees a propensity toward body-wide clotting, especially when other health or lifestyle variables are present. No matter the chemistry, however, when clots happen, we all seem genuinely surprised. If the results of this study show anything, it is that birth control induced blood clots are real and should be ruled out first, not last.

Sudden and Slow: The Two Faces of Pulmonary Emboli

One of the key goals of the Real Risk Birth Control Blood Clots study is to identify early warning signs of clotting. To that end, the women who took the survey were asked to identify the presence and severity of 35 symptoms commonly attributed to blood clots, at a month out, a week out, the day before, and the day of, the crisis. Although we found significant linear trends in the escalating severity of many symptoms across time for the group as a whole, more telling were the patterns that emerged when we divided the groups by diagnosis (DVT,  DVT + PE, stroke, etc.). There we see distinct patterns in the type of symptoms as well as the trajectory of expression and severity.

For example, when we look at the patterns of early warning signs of pulmonary emboli, we see two, possibly three, trends emerging. In some women, pulmonary emboli seem to appear suddenly with few if any warning signs. In other women, symptoms either increased over time or waxed and waned (or both), sometimes for months, until reaching an apex of severity. For the latter group, the waxing and waning seemed related to the movement of the clot(s) from the periphery to the lungs. That is, the localized pain, swelling, and temperature changes, either in the legs, pelvis, abdomen, or collarbone regions, would be severe for a week or a month before the event and then dissipate entirely, only to re-emerge as the crushing pain associated with the pulmonary embolism. We will be reporting more details in subsequent articles, but preliminarily, the data and the personal accounts suggest the possibility that PEs may be preventable, if the signs of deep vein thrombosis (DVT) are more readily recognized.

Listed below are descriptions of the events leading up to the crisis reported by women with pulmonary emboli who completed Phase 1 of the Real Risk Birth Control and Blood Clot survey. A similar report was published for women who survived strokes.

Sudden Onset

“my chest hurt to the point I could not lay down or move without excruciating pain” – during the crisis – no symptoms prior.

CS2 reports severe right thigh pain the day of the crisis, as well as moderate chest pain, shortness of breath and fatigue and mild back pain, but nothing before that point. The PE caused low blood pressure. Doctors were unable to detect blood pressure in her right arm.

JR began to experience mild discomfort the day before her crisis. The day of her crisis, she explains, “the symptoms [severe shortness of breath, chest pain, irregular heartbeat, dizziness, blackouts, fatigue, and mild to moderate headache, nausea, difficulty speaking, and stomach pain] worsened as the day went on.” She goes on to say that “right before I passed out and then once when I woke up, it was crushing burning pain and my heart was beating so fast that I couldn’t catch my breath.”

RF’s clots originated in the pelvis and legs and experienced severe pain and swelling in the pelvis the day before her crisis.

Tales of Traveling DVTs

“…right lower calf was swollen and warm to the touch, pain felt like a Charley horse. Chest pain was unbearable. It hurt to breathe and my heart was racing so fast that it hurt.” – per her data, leg pain developed a week before but disappeared; chest and heart pain appeared the day of the crisis; fatigue was moderate to severe from week before.

Twenty year old CS  reported moderate to severe right shoulder and chest pain a month before the crisis, along with moderate fatigue from a week out. The day of the crisis, the pain moved to lower chest. She describes the chest pain as: “Every time I took a breath in it felt like a knife was being stabbed into my chest on the right side.” Like so many others, she was sent home from doctor’s office day of crisis only to return to ER that night to discover her right lung was riddled with clots, necrotic in places.

KM had very few symptoms leading up to her PE, except a “sharp pain deep in my calf – I thought I had a badly pulled muscle or strain my Achilles tendon (up high) while jogging. The pain got much worse if I was standing for long periods of time, but got much better if I exercised.” She also reports shortness of breath climbing stairs or when giving a presentation.

ES described her symptoms: “leg pain felt like a bad cramp, almost as the back of the leg had seized up. I thought it was a pulled muscle because I lacked other symptoms. The PE pain was a crushing, hot pain in my chest, worse when breathing in.” Her leg pain began a month prior to the PE, peaked a week before and then dissipated entirely. While the pain from the PE began a week prior to the crisis and escalated.

FH rates all of the symptoms leading up to the crisis as mild, even though some of the symptoms emerged months before. She chalked up her leg pain to occasional muscle cramps and the shortness of breath to sinus issues.  It wasn’t until she began blacking out that she suspected something more serious was wrong. She notes on the day of the crisis she was cold and her blood pressure was extremely low.

KG reports that “a month before the clots my toes on the right side got red and swollen and felt throbbing. After working out at the gym had chest pain, shortness of breath, [my] ribs hurt, heavy chest that felt like extreme gas pains.”

KD describes how the pain seemed to move with the clot. “The pain in my left quad felt like an injury. Then when it moved to the ribs, it felt like I had pulled ribs. Then when it moved to the right side, it felt like a kidney stone and only hurt bad when I was lying flat on my back. My leg pain, after the clot had already exploded into my lungs, was like a bad Charley horse. My lungs had clots everywhere.”

SD reports severe leg pain 3-4 weeks before experiencing the difficulty breathing associated with her PE.

Waxing and Waning Symptoms

For 43 year old DW symptoms like dizziness, blackouts, and vomiting had emerged a week prior and then dissipated until the day of the event, when they returned along with severe shortness of breath, chest pain and heart palpitations. She describes the pain as “tight legs, stabbing pain and then collapsed. All happened within 5 minutes.

For DD the DVT that preceded the pulmonary emboli “felt exactly like a Charley horse. When it lasted more than two days and I started limping, I knew I needed to consult a nurse at the ER.” She too had symptoms that waxed and waned over the month preceding the crisis.

R indicated that she experienced breathing difficulties and chest pain that would wax and wane over the six months prior to her PE diagnosis and that it wasn’t until a few days before the crisis, that it became severe. “On the second night when I tried to sleep, I had severe pain in my upper back and left side of my chest, which started to radiate up to my neck and left shoulder. I experienced more pain in my chest if I tried to inhale deeply.”

Unremitting Fatigue as a Key but Non-Specific Symptom

Uncharacteristic and unremitting fatigue was one of the most consistently reported symptoms across all time points and diagnoses.

LL reports severe fatigue for at a least a month prior to the crisis as the leading symptoms. She notes the fatigue appeared well before the pain. “The fatigue leading up to this was very bad. It was such a struggle to get out of bed or do anything. It was there a good while before the pain.” She also reports restless legs, and “severe stabbing pains in my back” especially when “bending down to pick something up.”

Breathlessness and Speaking Difficulties

As one would anticipate with pulmonary emboli, difficulty breathing was a cardinal symptom of the impending crisis.

Breathing Difficulties

“felt like I had become rapidly, extremely unfit. Could not walk up the stairs in one go. Was struggling to get enough oxygen.”

J believes her symptoms emerged months before the crisis. She reports a “hairball-like cough” for months that was continually diagnosed as allergies. It was persistent and would not respond to allergy medicine. She experienced moderate to severe fatigue for the month leading up to the crisis, along with moderate to severe shortness of breath, irregular heartbeat, heart palpitations, cough, dizziness and nausea.

LT said “chest wall pain two weeks before diagnosis felt like soreness from lifting weights. When the back pain localized to my side and upper back, it felt like I had pulled muscles in those areas. The shortness of breath felt like I was getting out of breath way too easily; walking 30 feet felt like I had been running for half a mile, and slowly climbing the long escalator out of the subway station felt like I was trying to run up the stairs.”

SM experienced severe shortness of breath for at least a month prior to her diagnosis. She says she felt as though “…the middle of my chest was being pressed or squeezed.”

Speaking Difficulties

Many women report difficulty breathing in the months, week and day before the crisis. Speaking, because of the breathing difficulties, becomes increasingly labored.

NB said she would gasp for breath and was “only able to get 1-2 syllables between gasps.” She said she felt like she “had run for her life and just couldn’t catch my breath.”

JZ felt “very winded, even in casual conversations,” but otherwise didn’t report any symptoms.

Conclusion

These and other personal accounts of birth control-induced blood clots suggest that for many women, early signs are present but not recognized. Similarly, blood clots appear to be distributed throughout the body. This is consistent with the fact that hormonal birth control induces systemic changes in hemodynamics. To fully delineate the risks, however, we need more data. If you or someone you know has suffered from a birth control induced blood clot, please consider participating in the study.

We Need Your Help

More people than ever are reading Hormones Matter, a testament to the need for independent voices in health and medicine. We are not funded and accept limited advertising. Unlike many health sites, we don’t force you to purchase a subscription. We believe health information should be open to all. If you read Hormones Matter, like it, please help support it. Contribute now.

Yes, I would like to support Hormones Matter. 

This article was published originally on November, 2016. We subsequently lost funding to finish this study. Nevertheless, we are still accepting stories about birth induced blood clots. If you’d like to share your story, send us a note: Write for us. Other stories and articles about birth control and blood clots can be read here.   

Photo: autopsy of birth control induced pulmonary emboli in a young woman.  

 

Blood Clots, Birth Control and Female Athletes: Are We Missing Important Risk Factors?

9993 views

Over the last several years, stories of young women, many of them athletes (here, here), suffering from dangerous and sometimes deadly blood clots have filled the press and academic literature (herehere, here). Often mentioned in passing is the fact that these women were taking hormonal contraceptives at the time of the event. As a mom of a female athlete, a lifelong jock myself, and a researcher, I cannot help but wonder if we aren’t missing critical connections between some very common real life variables that predispose young women to serious health risks. Are athletic women more at risk for hormonal birth control-induced blood clots than other women? I think they might be.

We all know, or at least should know, that hormonal contraceptives increase the risk of blood clots for any woman who uses them. We often don’t pay attention to those warnings, especially when we are young, consider ourselves healthy, and when we are athletes. We ignore the warnings because taking birth control is, in many cases, a practical decision. Hormonal contraceptives, whether in the pill, patch, implant, vaginal ring, shot, or IUD, regulate if and when we bleed. That is, we bleed on a schedule, controlled entirely by synthetic hormones.

Scheduling is wonderful for female athletes. With no control over the scheduling of competitions, the ability to schedule one’s period is a great advantage. Let’s face it, competing while bleeding and cramping is never fun and near impossible for women with painful periods. Who wants to spend years training for that one event, only to have her period start? No one.

Optimal athletic performance requires that we control extraneous variables to the extent possible. Controlling one’s period takes care of a major variable in the life of the female athlete. And since it prevents pregnancy, hormonal birth control is a win-win.

Or is it?

Aside from the fact that hormonal contraceptives impact athletic performance (a topic of great debate and conflicting research), induce a variety of unwanted side effects, and that pill bleeds are not periods, hormonal contraceptives increase the risk of blood clots, quite significantly. Conservatively, birthcontrolsafety.org, estimates that out of the nearly 11 million women who use hormonal contraceptives (pill, patch, or ring), approximately 20,000 will develop blood clots and about 600 women will die, every year. There are no data on how many of these women were athletes or exercised intensely; however, it is likely that the numbers are pretty high given the high rate of hormonal contraceptive use in the general population.

Intense exercise, which is the foundation of athletic training, increases the risk of blood clots independently of gender or birth control usage. Indeed, some research suggests that the risk for deep vein thrombosis, blood clots in the legs, may be significantly higher for athletes than the general population. An interaction between hormonal contraception and exercise is likely to increase the odds of blood clots rather significantly. As women, the combination of those two variables alone should give us pause, but when we consider all of the other real world variables that also increase blood clotting and that just so happen to be prevalent in the life of the female athlete, the risk becomes quite concerning.

When Clots are Formed: Virchow’s Triad for the Athlete

When we look at the mechanisms involved in clotting and bleeding, we should remember that blood clotting itself is a necessary and protective mechanism against injury. Without the ability to clot, all sorts of complications can arise from everyday activities. Equally important are the body’s compensatory mechanisms that are designed to prevent too much clotting and to clear out clots once the immediate danger has ceased. The balance of power between the factors that promote clotting and those promote bleeding must be maintained within a fairly narrow window. Disruption to either side creates problems. Hormonal contraceptives shift that balance towards clotting and the normal components of athletic training and competition, shift the balance even further. When we add a few more variables, in any combination, synergies develop and the cumulative effects make female athletes using hormonal contraceptive at risk for serious, and sometimes deadly, blood clots.

Blood Clots and Athletes: The Basics

Blood clot formation is more likely when there are disruptions in blood flow. This can happen with:

  1. Injury to the blood vessel wall (even microinjury induced by a medication or chemical exposure)
  2. Depression of blood flow dynamics
  3. Changes to blood constituents (clotting factors)

These factors constitute what is called Virchow’s Triad, after the German pathologist Rudolph Virchow who developed a framework in 1884.

Off the bat, by using Virchow’s triad, we can identify several potential risks for clotting that are likely more prevalent for athletes, male and female. For example, periods of intense exertion increase blood pressure, heart rate and the shear stress on the vascular walls (inducing damage and inflammation), which increases clotting propensity for athletes; while conversely, the athlete’s slower resting heart rate and lower blood pressure when not in competition, makes clearing those clots efficiently much more difficult. Similarly, periods of dehydration increase blood viscosity, slowing blood flow, as does inflammation and muscular hypertrophy via venous or arterial compression. Injuries and surgeries damage the vascular and arterial plumbing and slow blood flow. Extended travel compresses leg vasculature (and sometimes arm vasculature depending one’s sleeping position) and slows blood flow. Heck, even repeated movements can compress veins or arteries in different regions of the body and slow blood flow. What is athletic training if not repetition, hours upon hours of repetition?

Now consider these variables occurring against the backdrop of hormonal birth control, which changes the very balance of power between clotting and bleeding, effectively overriding many of the systems in place to ensure that clots don’t persist and causes problems. Throw in a few other decidedly female variables that also increase clotting, like monthly NSAID use to stave off menstrual pain, a propensity towards headaches and migraines, a latent genetic disorder or two, maybe even a less than optimal diet, and we have a recipe for disaster.

A Deeper Dive: Common Clotting Triggers for Athletes

Injury to the blood vessel wall

Injury to the blood vessel wall can develop by a number of mechanisms. The most obvious are those that result from direct injuries that occur over the course of training or competition. Surgery falls into this category. The rate of blood clots that evolve into pulmonary emboli after shoulder surgery ranges from 0.17% – 5.1% depending upon the type of surgery. Deep vein thrombosis after knee surgery, however, complicates some 2-13% of cases and upwards of 60% with some procedures. We cannot forget, also, that women are apt to have surgeries related to reproductive health issues, e.g. those related to endometriosis or ovarian cysts.

Less obvious are the micro-injuries or insults to vascular endothelial cells. Micro-injuries are surprisingly easy to induce over the course of athletic training and even in everyday living. They are not commonly recognized as risk factors for blood clots and there are few data that address these types of injuries; perhaps because their effects are likely part of a more complicated set of variables that combine to initiate and/or prolong the clotting, and are not immediately identifiable. I would argue that we ought to consider these risk factors especially in female athletes who use hormonal contraceptives because they are likely quite common. Here are just a few.

Contrast Dyes used for Imaging

Before any injury is surgically managed, imaging studies are common. The contrast dyes used for these studies induces micro-injuries to vasculature where the dye is circulated and are known to induce clots.

Vaccines and Medications

A number of medications and vaccines induce varying degrees of vasculitis or vascular microinjury. The most recent evidence of this is the HPV vaccine. For female athletes, something as simple as this or other vaccines, could initiate a clotting cascade that becomes difficult to end when hormonal contraceptives are involved. Similarly, the most commonly prescribed class of antibiotics, the fluoroquinolones (Cipro, Levaquin, Avelox and others), induce vascular microinjury among other side effects (tendon rupture, rhabdomyolosis, and neuropathy to name but a few).

Nutrient Deficiencies

Nutrient deficiency can induce vascular injuries via mitochondrial cascades. This one is a little bit more complicated and often a longer term process but one that adds to the overall propensity to clot. Briefly, mitochondria are responsible for and/or involved with a long list of functions ranging from bioenergetics (ATP production), to inflammation, steroid synthesis and cellular apoptosis, even platelet aggregation (an important variable in clot formation and dissipation). Mitochondria need several core nutrients to power enzymatic reactions. Most folks, even athletes, are deficient in several of these nutrients, especially if on hormonal contraceptives. Hormonal contraceptives deplete vitamins B1 [thiamine], B2 [riboflavin], B6, B9, B12 (worse if one is a vegetarian/vegan), C, E, magnesium (many athletes are magnesium deficient regardless of contraceptive usage), zinc, and CoEnzyme Q10. Simultaneously hormonal birth control may elevate vitamin K concentrations (which increases clotting), and also, increase copper and iron (too much iron favors hypercoagulation). Nutrient deficiencies and abnormalities cause mitochondrial dysfunction (and a whole host of other problems). Mitochondrial dysfunction leads to cell dysfunction, leading to molecular changes in the vasculature (and elsewhere), injuries, and a propensity for clotting ensues. Mitochondrial damage would also lead to changes in blood flow dynamics and blood constituents. So mitochondrial damage, though more subtle, can affect the entire triad of variables.

Blood Flow Dynamics – The Plumbing

Compression

Like the pipes in our houses, anything that blocks or compresses or otherwise slows the fluid through the pipes can induce a clog or, in this case, a clot. The most obvious of these factors is compression, as occurs on long plane/train/bus trips to and from competitions. According to AirHealth.org:

About 85% of air travel thrombosis victims are athletic, usually endurance-type athletes like marathoners. People with slower resting blood flow are at greater risk of stasis, stagnant blood subject to clotting. Also, they are more likely to have bruises and sore muscles that can trigger clotting. No other risk factor comes close to this. Age over 60 is supposed to be a risk factor, but these victims are younger, 82% of them under 60 [47% of air travel thrombosis cases are between the ages of 20-44].

According to some reports, the increased risk for clotting continues for up to 24 hours post competition, making the long trip home after an event particularly risky.

These are staggering numbers which are likely under-reported and under-studied. Imagine the risk for compression induced clotting to the female athlete who uses hormonal contraceptives. If she’s had an injury that required imaging with a contrast dye, or experienced any of the aforementioned other vascular insults, the risk increases.

May-Thurner Syndrome. Twenty percent of the population is believed to have a narrower than normal left iliac vein leading to blood clots in the pelvic region and left leg. May Thurner Syndrome, Pelvic ClotsMost do not know this until they end up in the hospital with a blood clot. For these women, the risk for deep vein thrombosis, particularly in the left leg is even higher, especially on birth control (most especially, I believe, though this is pure speculation, when using a cervical ring like the NuvaRing). Again, add long sit times, an injury perhaps, and we can begin to see how the risk for blood clots in the female athlete using hormonal contraception can be much higher than for her teammates who do not use hormonal contraceptives.

Paget-Schroetter Syndrome, an anatomical narrowing of the subclavian vein (just under the clavicle or collarbone) and repetitive use trauma either alone or together can initiate clotting from this region. Sports with high upper-body repetition such as swimming, gymnastics, rowing, tennis, baseball/softball, and others, are at most risk.

subclavian vein effort thrombosisIt is believed that the repetitive trauma that these sports require imposes strain on the subclavian vein leading to microtrauma of the endothelium and activation of the coagulation cascade. This alone is a risk factor for developing a blood clot, but when we add a few more variables, an intense competition, dehydration, a long flight home with upper body immobility and perhaps compression (sleeping on one’s arm), and enter these variables into an system primed for coagulation by hormonal birth control, the risk for dangerous blood clots increases significantly.

Viscosity

Sludgy matter doesn’t move through pipes too well. All manner of variables can affect the viscosity of blood. The most common in athletes is dehydration.

Dehydration

Dehydration is common in athletes, especially after a long competition. Dehydration increases the viscosity of the blood, slows the movement through the pipes. Put a dehydrated female athlete, who uses hormonal birth control on a long bus trip home, and clot risk increases. Add some past vascular damage, even minute and unrecognized, plus an injury or two, and the risk increases even more.

Blood Constituents – Changes at the Molecular Level

We can change the intrinsic clotting factors by a number of mechanisms: genetic, epigenetic and via medications (like birth control, NSAIDs and others) or environmental chemicals. There are over 20 proteins involved in maintaining the balance between clotting and bleeding and each of them can be altered towards a pro-clotting state by a myriad of variables (for a full list see here).

Genetics

Beginning with the genetic variables, 3-10 % of the population have heritable genetic mutations that increase their risk of developing blood clots quite significantly, absent other variables. Upwards of 50% of patients who have develop a clot carry one or more of these mutations. Unless there is a known family history of clotting disorders, most women who carry these mutations are unaware of their genetic risks. When these women utilize hormonal contraceptives, their risk of blood clots increases significantly by as much as 35x according to some data. I think all women should be tested for these genetic variables before being given hormonal birth control. Unfortunately, none are, until they end up in the hospital fighting for their lives. Now consider a female athlete who carries one of the mutations and is on hormonal birth control, travels, uses NSAIDs, has had an injury or two, and the likelihood of her developing deadly blood clots is very much increased.

With both genetic and acquired components, antiphospholipid syndrome (APS or APLS), also increases blood clot propensity. In fact, it is the most common cause of excessive clotting, and affects women more than men. APS is autoimmune condition that causes hypercoagulability of blood through unknown mechanisms. APS can occur on its own, or in conjunction with lupus and other rheumatic disease processes like Sjogren’s. Neither of these diseases is uncommon in female athletes, though hard data are difficult to come by. Anecdotally, Venus Williams has struggled with Sjogren’s and case reports abound of female athletes with Lupus (here, here).

Epigenetics

Epigenetics is a fancy term for events that happen above the genetic level. It is an emerging science where investigators look at variables that don’t directly alter the DNA, but rather, aberrantly turn on or off a particular gene. Environmental factors play a large role in epigenetics, medications, vaccines, other chemicals, diet and nutrition. So, just as a woman can carry heritable genetic mutations, she can also carry heritable epigenetic changes that turn on the genes controlling the clotting proteins or turn off those that prevent clotting. We can inherit these epigenetic changes from parents and even grandparents, but also, induce them via every day exposures and activities. I suspect that there are epigenetic components of one’s risk for blood clots.

Medication Induced Clotting

Here’s the big one that we don’t pay nearly enough attention to – medications and vaccines can induce clotting via multiple mechanisms, including changing the balance of power between clotting and bleeding. Briefly, and most importantly to female athletes are hormonal birth control and NSAIDs (ibuprofen and the like). The chemistry is a bit complex, but let us take a stab at it, because when these variables are combined with the normal activity of a female athlete, I believe her risk for blood clots shifts from the ‘if’ category to the ‘when’ category. For more information on the clotting cascade, here is a simple Khan Academy video.

Hormonal birth control increases all of our coagulation factors, but most especially, clotting factors VII and X, where plasma concentrations have been measured at 170% of normal. Fibrinogen (responsible for initiating the fibers that form the clot) is increased by 20%. Hormonal contraceptives also stimulate platelet aggregation (the initial plug that covers the injury), while simultaneously decreasing an anti-clotting factor called antithrombin III. Sit with that for a moment. This is the biochemical foundation that the female athlete is working with. Without doing anything else, her body is primed to clot.

Pro-clotting factors are increased to almost 3X their normal levels, while anti-clotting factors are diminished.

With this biochemistry, a body can only forestall excess clotting for so long. In fact, early reports suggest that clotting risk increases with time used. That is, clotting factors increase over the months and years one uses these medications. This may be why some of the most deadly clots, the pulmonary emboli and cerebral venous thrombi develop in women who have used contraceptives for years.

I have to add one more poorly understood hit to the coagulation system. NSAIDs alter platelet aggregation in some pretty complex ways and the mechanisms by which NSAIDs induce bleeding or clotting are just beginning to be understood. It is well known that NSAIDs like aspirin and ibuprofen can induce excessive bleeding. Gastric bleeds are one of the most common side effects of ibuprofen use. NSAIDs also carry with them increased risk of venous thromboembolism. Excessive bleeding but also excessive clotting–how is that possible? Certainly, it depends upon the formulation and which pathways the drug targets (Cox 2 inhibitors), but the emerging theory is that platelet aggregation may increase over time and become difficult to dissipate, because these medications block the enzyme responsible for keeping injured vessels free of clots while the damage is being repaired.

Another mechanism by which NSAIDs influence coagulation is via heart rhythm irregularities, like atrial fibrillation (at least for older populations, no data are available for younger athletes). With atrial fibrillation, we have a good chance of blood pooling which can result in clot formation. Finally, there is some evidence that NSAIDs increase vasoconstriction, which would impact blood flow. NSAID use is very common in the life of the female athlete and non-athlete alike with regular use both monthly, to stave off menstrual pain, and over the course of training to manage pain and injuries. It is possible that NSAID use may not only impact the post-injury healing process, but also, increase an athlete’s chances of developing a blood clot.

Now What?

Birth control is a personal choice. If pregnancy prevention is the only reason for using these hormonal contraceptives, there are non-hormonal options, including the old stand-bye, the condom, and newer devices for tracking. If scheduling is the primary consideration, I would consider whether or not the opportunity to schedule overrides the risks associated with using these products. Blood clots are a very real danger for athletic women without the additional risks that come with hormonal birth control. Are those risks worth taking?

Share Your Story

If you are a female athlete and have developed blood clots while using hormonal contraceptives, consider sharing your story. Contact us via this link: Write for Us.

We Need Your Help

More people than ever are reading Hormones Matter, a testament to the need for independent voices in health and medicine. We are not funded and accept limited advertising. Unlike many health sites, we don’t force you to purchase a subscription. We believe health information should be open to all. If you read Hormones Matter, like it, please help support it. Contribute now.

Yes, I would like to support Hormones Matter. 

Photo by John Arano on Unsplash.

This article was published originally February 23, 2016.

Profits Over People: Medication Risk and Drug Company Misconduct

5928 views

If you haven’t read Chandler Marrs’ article on the safety of medications, take a moment to do so and understand that no medication is, as Marrs puts it, “perfectly safe.” I’m here to reaffirm this harsh pill to swallow (pun intended) through the telling of my own experience and the showcasing of research that reveals just how much sway Big Pharma has over the safety of medications.

I was 20 years old when I decided to take my doctor’s advice and go on hormonal birth control to help regulate my periods. I remember my mother, a registered nurse who worked in a local hospital, voicing her concerns about the oral contraceptive. At the time, she was seeing quite a few girls my age come in with clotting complications related to the pill.

Thinking I knew what was best for me, I ignored her advice to stay off of the medication. I was comforted in knowing that almost every single one of my close friends was taking some form of birth control, and they were fine. I’d be fine too.

I couldn’t have been more wrong.

Two months later, I was in the emergency room with a bilateral pulmonary embolism or multiple blood clots in my lungs. What I originally thought was a relatively safe medication turned out to be a life-threatening decision. Suddenly gone forever was my notion that any medications I was prescribed would be taken without risk.

After six months on blood thinners to dissolve the clots, I went back to living my life normally, both clot and birth control-free.

Fast forward four years, and I’m reading news stories discussing the thousands of lawsuits that have been filed against the makers of Xarelto, the same blood thinner I was prescribed to help me recover from my embolism. Although I suffered no complications from the medication, I was clearly one of the lucky ones this time. The anticoagulant, which is still on the market today, has no known antidote to reverse its blood-thinning effects, and it has caused so many severe internal bleeding incidents and deaths that legal action has been taken.

Prior to doing any research, my emergency room experience would have made me cast aside the lawsuits as frivolous. There’s a risk with any medication; I can’t deny that I knew the risks before I opted to take birth control. But, didn’t they also know the risks before agreeing to take the blood thinner just like I did?

Drug Company Misconduct

After digging deeper, I realized there was a bigger issue at hand. Drug companies wield an incredible amount of influence within the healthcare sphere that can lead to the approval of medications that should never find their way into patients’ hands in the first place. A major showcase of this influence is seen in Big Pharma’s ability to fund clinical trials.

These clinical trials must be conducted before a drug is approved for market, and funding has typically come from government sources like the National Institutes of Health. But in recent years, more and more industry-funded clinical trials are taking place, meaning that drug companies can sponsor their own medications studies. Critics of this funding allowance point to the fact that the potential for financial gain can lead to a conflict of interests. Companies that have a vested interest in a drug’s approval because it brings a boost in profits could favor positive outcomes while ignoring any negative results.

In the case of Xarelto’s industry-funded clinical trial, it was discovered that Johnson & Johnson withheld information from the FDA that would have highlighted the blood thinner’s inferiority to its comparison warfarin. During the study, 14,000 patients were given an overdose of the traditional anticoagulant due to the use of a faulty blood-testing device, decidedly skewing the results. The design of the company-sponsored trial also limited the distribution of Xarelto to once-a-day dosing that weakened the medication’s effects on participants. With less severe side effects being observed because of the smaller dose, Xarelto’s clinical trial looked favorable for the new experimental drug.

We see a similar story of clinical trial misconduct being told with another blood-thinning medication, Pradaxa. Pradaxa was put through an industry-funded study whose poor trial design led to FDA approval. Critics point out that there was probable cause for bias since it failed to be a double-blind study. Its trial participants were also made up of a demographic of people who were less likely to be prescribed the medication once it hit the market.

The FDA went on to approve the anticoagulant despite the lack of an antidote, but its decision was based on the fact that Pradaxa “wasn’t inferior” to traditional warfarin. This labeling could bring the drug to market, but it wouldn’t be able to give manufacturer Boehringer Ingelheim a leg up in its promotion of the medication. Therefore, the drug company requested that Pradaxa be labeled as “superior” to warfarin in its ability to reduce strokes so that it could make this claim in its marketing materials. The FDA granted the company’s request, decidedly ignoring its original concerns with the blood thinner.

Pradaxa hit the market without an antidote just like Xarelto, and I bet you can guess what happened next. Thousands of patients taking the medication suffered severe internal bleeding complications and even succumbed to the side effects. Like Johnson & Johnson, Boehringer Ingelheim faced a shocking number of Pradaxa lawsuits and created a $650 million settlement fund in 2014 to satisfy the claims.

Profits Over People

We cannot deny that every medication presented to us comes with some sort of risk to our overall health and well-being. I suffered the risks of birth control but miraculously avoided the complications associated with Xarelto. Costs and benefits are just a fact of the pharmaceutical industry.

But, the issue lies in the influence of Big Pharma. If drug companies, who are so clearly focused on boosting their profit margins, can impact clinical trials in such a way that it costs patients more than it benefits them, where do we draw the line?

It will take massive changes in the drug approval process and overall state of healthcare before we can start to see patient lives being placed above profits. But, what we can do is stay informed and educated on the prescriptions we’re taking. There is a lot going on behind the scenes before a medication makes its way into that little orange pill bottle, and it’s up to us as consumers to do our research, look into the possible complications, and voice any and all concerns with our doctors.

We Need Your Help

More people than ever are reading Hormones Matter, a testament to the need for independent voices in health and medicine. We are not funded and accept limited advertising. Unlike many health sites, we don’t force you to purchase a subscription. We believe health information should be open to all. If you read Hormones Matter, and like it, please help support it. Contribute now.

Yes, I would like to support Hormones Matter.

Image by Thomas Breher from Pixabay.

This article was first published in January 2018. 

Birth Control Induced Pulmonary Embolism While Driving

2226 views

I am a 37 year old woman who has been taking birth control since I was 15 years old and I had a pulmonary embolism (PE) while driving last year. I was on Aviane for over 6 years and then switched to Camrese on 9/19/18 and was taking that up until the PE on 12/13/2018. Before going Aviane, I was on many other generic forms of estrogen type birth control since I was 15 years old. My main reason for taking birth control was to control my cycle. Preventing pregnancy came later on in my adult life.

On December 13th, 2018, I was traveling home from a Tribal Belly Dance Retreat in Hawaii. I was in the best shape of my life and was really enjoying my life to the fullest. While driving from the Phoenix Airport to Flagstaff Arizona, I started to feel tired. I felt like I was going to pass out. The anxiety of that feeling was intense. Within an hour after I started driving, I lost consciousness on Interstate 17 going northbound and then I came to, going 75mph. I lost control of my car and flipped 4 times, continuing to gain and lose consciousness, until the car stopped. I had no idea I was having a pulmonary embolism, until I reached the hospital and they saw something odd in my MRI.

During the crash, I was terrified. I really thought I had gone to hell. After the car stopped rolling, I was alone and could not figure out how to get out of the car. I passed out in fear and then woke up outside of my car, wandering around. At some point, I picked up four tarot cards from the mess of the paperwork and luggage that was thrown from the trunk of my car. I was completely alone in the middle of highway. Luckily my car rolled into a patch of rocks and grass, instead of the area I had just passed, which would have left me in a ditch of one of the multiple cliffs along Interstate 17.

The next thing I know, a truck driver came from out of nowhere and called 911 to get me help. I have not been able to get in touch with that truck driver who saved my life or the ambulance EMT that rode from Sedona to Flagstaff with me and kept my spirits up during the most confusing and scary time of my life. I would really like to thank them for their kindness.

At the hospital, they identified the pulmonary embolism through an MRI. I was shocked and freaked out, to say the least. That night at the hospital, I went into convulsions and had a mini-seizure, which lasted about half a minute. After four days, they released me from the hospital. It was noted that I would be on blood thinners for 6 months. I was not able to return to work until January 21st and only then with a limited work schedule of only 4 hours a day. I just recently returned to work on a normal schedule on February 12th.

This has event has left me with a totaled car, monstrous hospital bills and limited funds to pay for it all due to how long I was out of work. I am also at a loss for words that the mental stress it has caused. I will never be the same but I am thankful that I am alive.

Prior to the pulmonary embolism, I was a casual social smoker, smoking only 1-2 cigarettes every 2 weeks. I have since stopped completely. I was generally healthy but had one issue that my naturopath said was related to the birth control. I developed chronic salivary gland stones and had about 5 of them removed in 2014. My body has produced them since 2005 and all of the doctors I have seen, have never been able to tell me why, except my naturopath, Dr. Brandi Gowey. She said at one point that she thought they were a result of the birth control I was taking and had recommended that I come off the birth control. I obviously did not take that advice. I wish I had.

We Need Your Help

More people than ever are reading Hormones Matter, a testament to the need for independent voices in health and medicine. We are not funded and accept limited advertising. Unlike many health sites, we don’t force you to purchase a subscription. We believe health information should be open to all. If you read Hormones Matter, like it, please help support it. Contribute now.

Yes, I would like to support Hormones Matter.

Blood Clots: What Women Know Versus What We Should Know

2891 views

I was on the birth control pill for ten years. I knew that it could cause blood clots in women over 35 who smoked. I wasn’t over 35 and I didn’t smoke. That was all I thought I needed to know. Then I had a stroke. It was caused by the pill and a genetic clotting disorder I never knew I had. In fact, I didn’t know there was such a thing as clotting disorders or that I could have one or that in combination with hormonal birth control, it could kill me. And I certainly had no idea what the symptoms of a blood clot were.

What Do We Know? Not Too Much, It Appears

When I began to do research for my thesis, I wanted to know if it was just me or if other women who took the pill were also unaware of clotting disorders and of the symptoms of a blood clot. Spoiler: I wasn’t alone in my ignorance.

I surveyed over 300 women who had taken birth control pills. Among other things, I wanted to know:

  • What did women know about the risks associated with the pill?
  • Were they aware of clotting disorders?
  • Did they know the symptoms of a blood clot?

Survey Results

Neither Women Nor Their Doctors Understand Risks for Blood Clots

The results of the survey showed that women do not clearly understand the risks involved with taking birth control pills. Many of them believe that certain risks are only associated with being over 35 years of age and/or smoking. This is not surprising given that only a little over half said their doctor discussed the risks with them before giving them a prescription. And for a majority of the women, their doctor never discussed other birth control options with them.

Most of the women were asked about their family history before being given a prescription, but fewer than half of their doctors actually discussed it with them, and fewer than a third of the women actually read the risk information that accompanies their prescriptions. That’s not surprising given how dense and misleading the pharmaceutical companies have made risk communication.

When asked whether they were familiar with the symptoms of a blood clot, most women (60.5%) admitted that they were not. Eight women responded that they had learned the symptoms because a family member or friend had a blood clot, and two participants said they had actually had blood clots. One stated, “When I experienced chest pain and did research online. It turned out that I had pulmonary embolisms (while on BCP- birth control pills).” Only 6 out of 311 women reported learning about the symptoms of blood clots from their doctor. Ironically, more women knew someone who had a clot.

At the end of the survey, the participants were invited to share anything further about their experience on the pill. Here are some of their answers:

My experience on birth control pills, the Nuvaring, or Depo-Provera all proved to be horrendous… I think birth control pills came straight from hell and I hate, hate, hate it. I would rather undergo Chinese water torture daily thank take birth control, and that is the God’s honest truth… My fertility has been affected forever by my under informed choice to go on birth control, and by the irresponsible doctors who encouraged me to switch methods rapidly “until I found what worked for me.”

 

I’ve had two different GYNs give me completely contradictory information about the side effects and dangers of BCPs… Overall, I’m surprised at how little doctors seem to know about female BCP- I haven’t experienced this amount of ambiguity with any other medical specialty or problem.

 

I was shocked- and grateful- when I finally found a doctor who discussed alternatives with me, suggested a wide variety of reading, and let me do my own research and make my own decision before wiring[sic] a prescription. After doing the reading, there is no way I will ever take another birth control pill in my life. Every other doctor I had acted like it was giving out Altoids…

 

I think they’re too often the first option doctors prescribe for reasons other than birth control. That’s frustrating. They’re not a magic pill and some doctors seem to think they are.

The bottom line is that most women do not fully understand the risks involved with taking birth control pills and they are not familiar with the symptoms of a blood clot.

At my thesis defense, when I mentioned that most women (over 60%) did not know the symptoms of a blood clot, my advisor asked, “Well, I don’t think that’s so unusual. Do you think most people know what the symptoms of a blood clot are?”

“No, but I think people who have been prescribed a medication that greatly increases their risk of blood clots should be informed of the symptoms,” I responded.

Who Is Responsible?

This is a simple question with a complicated answer. Who is responsible for making sure women who use hormonal contraceptives, especially women who are at a much higher risk for blood clots, understand the symptoms and when to get help? Is it the responsibility of the doctor who prescribed the medication? Or is it the responsibility of the pharmaceutical company to provide clearer information? Or is it the responsibility of the patient?

From my personal experience, I now know that I cannot trust my doctor to always make the right diagnosis and provide the right treatment. Most of their information comes from the pharmaceutical industry who have clearly demonstrated that they put profit first. And our research is showing that their information is not correct. Therefore, I cannot rely on the drug companies to make sure they provide me with accurate and straightforward information about their medications.

So that leaves me. And you. Until we demand a system that puts patients first, a system of health and transparency, we have to put ourselves firsts. How? We do that by listening to our bodies, doing the research, and learning to trust our intuition. That may mean we have to disagree with our doctors. That may mean we have to ask for a second opinion. That may mean we have to insist on being heard. We can’t be afraid of offending someone or “rocking the boat.” We can’t be afraid of being considered hysterical or melodramatic. We can no longer sit back and hope others are making the best decisions for us. We have to educate ourselves. We must be our own advocates. Our lives depend on it.

And we can start by learning the symptoms of a blood clot.

What Are the Symptoms of Blood Clots?

 Blood clot in leg:

  • swelling
  • pain
  • tenderness
  • an unusually warm sensation in the affected area
  • an unusually cold sensation in the affected area (this is per our research, more details to follow)
  • pain in your calf when you stretch your toes upward
  • a pale or bluish discoloration

Blood clot in chest:

  • sudden shortness of breath that can’t be explained by exercise
  • chest pain, may feel like extreme heart burn
  • palpitations, or rapid heart rate
  • breathing problems
  • coughing up blood
  • dizziness (per our research)
  • uncharacteristic fatigue (per our research)

Blood clot in the brain:

  • severe headache
  • loss of speech
  • numbness or tingling of limbs
  • difficulty seeing or changes in vision
  • difficulty speaking or finding words

For more information about blood clots, especially in conjunction with hormonal contraceptive use, click here.

Fatal Pulmonary Embolism with No Warning Signs

2923 views

As a recent 23 year old college graduate, our daughter was entering into an exciting new phase in her life, when it was tragically cut short by a pulmonary embolism caused by her birth control pill.

In April 2013, Alex graduated from the University of Pittsburgh with a double major in communications and writing. At the beginning of that year she had entered into a relationship. So, during her Spring Break visit to her family home in Houston, she and her mother visited a doctor where she was prescribed Lutera for birth control. She seemed to feel well on it and never complained of any alarming symptoms to her mother or me. Following graduation she found work with an oil and gas marketing company in Pittsburgh and decided to stay up there, moving into a house with several other young women.

On the afternoon of October 30th of 2013, whilst waiting for the elevator with a co-worker, she suddenly collapsed. The co-worker called an ambulance and she was taken to St. Clair hospital, the closest facility. Her co-worker said that she was having shortness of breath, chest pain, and heart palpitations before she collapsed. During the drive there, the EMT called us in Houston and advised that our daughter had had some sort of seizure and was being taken to hospital. Her co-worker told us not to worry too much as it seemed to be an epileptic fit or similar and that she’d be fine.

About one hour after the first call we received a call from the emergency room doctor who advised that, if at all possible, we should get up to Pittsburgh STAT. By this time her boyfriend and a good friend of ours had arrived at the hospital, so we were able to get regular updates as we rushed to the airport. The main issue seemed to be that they wanted to life-flight her to the main hospital campus, but that it was proving difficult to stabilize her. A CT scan had confirmed a pulmonary embolism in her lung. We arrived in Pittsburgh approximately six-and-a-half hours after the first call, but she had died two hours before our arrival.

In talking with her boyfriend he told us that everything had been fine, although on the morning of her death she’d mentioned that her ‘butt’ felt like it had a pulled muscle. In addition, Alex had eaten dinner with our friend the night before, and had apparently mentioned that she felt tired. But there were really very few warning signs that could have alerted her or us that something was wrong leading up to her death.

This sudden loss has devastated us, forever changing our lives. It’s vital that all women who consider birth control of any sort should be aware of the risks, particularly those arising from the use of hormonal-based contraceptives. There are too many tragedies like that of Alex’s.

Real Risk Study: Birth Control and Blood Clots

Lucine Health Sciences and Hormones Matter are conducting research to investigate the relationship between hormonal birth control and blood clots. If you or a loved one have suffered from a blood clot while using hormonal birth control, please consider participating. We are also looking for participants who have been using hormonal birth control for at least one year and have NOT had a blood clot, as well as women who have NEVER used hormonal birth control. For more information or to participate, click here.

Birth Control and Blood Clots: Where Do We Go from Here?

2691 views

When I was 28 years old, I had a massive stroke (a cerebral venous thrombosis in the sagittal sinus area) from a combination of birth control pills and a fairly common clotting disorder, Factor V Leiden. You can read my story here (Part 1, Part 2, and Part 3).

As I mentioned in a previous article, I’ve recently been contacted by an amazing group of people who are making it their mission to research and share information about the safety of hormonal birth control and other women’s health issues. In looking for answers about her daughter’s death from the Nuva-Ring, Dru West came across my thesis online and contacted me about my research. After a series of equally serendipitous events, I was then invited to be part of a research team who will further study blood clots and hormonal birth control. I’m embarking on this journey to share what I find—the good, the bad, and the ugly. I’m embarking on this journey with the hope that we can prevent what happened to me from happening to other women. I’m embarking on this journey for the countless women who lost their lives by taking these drugs for birth control, for irregular periods, for acne, or the myriad other reasons for which they have been prescribed.

My role in this project includes sharing my own story, the research from my thesis, and combing through 1500 pages of congressional testimony from the 1970 hearings about birth control pills. These documents, the Nelson Pill Hearings, have been fascinating and overwhelming. And more than anything they’ve made me want to know more. I want to find out what was known about hormonal birth control back then and how the research has or hasn’t changed since. I want to know why synthetic estrogen was banned in chickens because it caused cancer in animals at the same time it was approved for women (at 100,000 times the quantity). I also want to understand why no women were allowed to testify at these hearings (they were kicked out). And I can’t wait to share what I find with you.

Like so many issues, women’s healthcare is complicated and multi-faceted. And I plan to explore all the possible strings tied up in this knot. Starting with the research from my thesis, I’ll be writing pieces about risk communication, clotting disorders, what women really know, and what they need to know. I’ll be sharing what I find in the Nelson Pill Hearings. And I’ll be investigating other women’s health issues as they come up, or as you bring them to my attention. At times I may get angry, I may get snarky, I may get overwhelmed. But I promise I will try to be as thorough, honest, and real as I can. We may be a small community—those of us who know there are far more dangers in these drugs than the pharmaceutical companies want us to believe—but we are smart and we are strong. And when we all come together to share knowledge, we are powerful. I hope that you will join me on this journey. Unlike corporations who have no problem putting a dollar value on the life of a person, I believe that if we can save just one woman from what happened to Julia, to Brittany Malone, to Erika Langhart and so many others, then all of this work will be worth it.

Real Risk Study: Birth Control and Blood Clots

Lucine Health Sciences and Hormones Matter are conducting research to investigate the relationship between hormonal birth control and blood clots. If you or a loved one have suffered from a blood clot while using hormonal birth control, please consider participating. We are also looking for participants who have been using hormonal birth control for at least one year and have NOT had a blood clot, as well as women who have NEVER used hormonal birth control. For more information or to participate, click here.

Blood Clots With Hormonal Contraception

6852 views

Over 80 percent of American women use hormonal contraception at some point in their lives. Many women who have taken birth control pills, or used other hormonally-based birth control methods such as implants, patches, vaginal rings, and hormone-emitting IUDs are probably familiar with the common side effects like fatigue, loss of libido, mood effects, headaches and breast pain. However, many women may not be aware that taking almost any form of hormonal contraception increases their risk of developing blood clots, a condition that can range in severity from asymptomatic to fatal.

The risk of developing a blood clot varies depending on the type of hormonal birth control used. One might assume that the newer methods would be safer, but in fact, they are more dangerous. The newer birth control pills (formulations containing drospirenone, desogestrel, gestodene and dienogest) confer a higher risk of blood clots than older formulations (containing norethindrone acetate or levonorgestrel, as well as the newer norgestimate). And the risk from patches and vaginal rings are the highest of all. It seems that regulatory agencies are willing to lower safety for the sake of user convenience, something that most women using hormonal contraception probably would not agree with, if they knew they were being put at risk.

The overall risk is considered low, with about 1 in 10,000 reproductive age women per year developing a blood clot. However, the older birth control pills increase the risk by about four-fold, and the newer birth control pills by five to seven-fold compared to non-users of hormonal contraception. There has been a substantial increase in the incidence of blood clots for the period of 2001 to 2009, compared to the years prior, likely because of the increase in use of newer hormonal birth control pills and the vaginal ring (Nuvaring). And because approximately 20 million American women use hormonal contraception, these relatively small risks translate into significant numbers of cases each year.

Every woman who is using hormonal contraception deserves to know accurately what the risks are, in order to make an informed choice of method of contraception, yet these risks are not often being communicated by doctors. And considering that taking any form of hormonal birth control at all raises the risk of developing a blood clot, every woman on hormonal contraception should know what the warning signs are, and seek medical help if they experience those signs or symptoms. Knowing these warning signs could save your life. Described below are signs of blood clots in various locations in the body.

Blood Clots In Legs, Arms, and Lungs

Blood clots can develop in any vein but most commonly develop in the leg, and sometimes in the arm. This type of blood clot is called a venous thromboembolism (VTE). These clots can break off from the spot where they initially form in the body, and travel to the lungs, causing a pulmonary embolism (PE), which is fatal in about 10 percent of cases within the first hour, and 30 percent of cases subsequently. Sometimes the VTE leading to the pulmonary embolism was asymptomatic or undiagnosed, and PE is the first indication of the presence of a blood clot. Even pulmonary embolism is often misdiagnosed at first.

Signs of VTE include pain or tenderness only in one leg or arm, swelling and/or red or blue discoloration of the affected limb or an area of the limb, and the leg or arm may be warm to the touch. Signs of a PE include sudden shortness of breath, chest pain that is sharp or stabbing and may get worse with deep breathing, rapid heartbeat, and cough (sometimes with bloody mucous). For information about how VTE and PE are diagnosed, see How is DVT Diagnosed? and How is PE Diagnosed?.

Blood Clots In the Veins of the Brain

Cerebral venous thrombosis (CVT), which is a type of stroke, is caused by blood clots in the veins of the brain. This condition is even more under recognized than DVT and PE, and comprises about one percent of all strokes. Using oral contraceptives has been shown to increase the risk of CVT up to 22-fold. This study is on the older side, performed before more widespread use of newer birth control pills, so the risk is likely even higher. In the past, this condition was fatal much more often, but now the diagnosis has been improving, and the mortality in various studies ranges from 5 to 30 percent. About 15 percent of patients who survive can have continued neurological impairment. CVT can be diagnosed using a combination of clinical signs and symptoms, and imaging such as MRI.

Signs and symptoms of CVT can vary depending on where the clot is in the brain. Headache is a common symptom, sometimes accompanied by nausea and vomiting. Seizures can also occur. In addition, neurological problems can be present, such as: paralysis or weakness on one side of the body, decreased vision on one side, difficulty speaking, or dizziness.

Blood Clots In Arteries

Like in veins, blood clots can form in almost any artery in the body. And similar to venous blood clots, clots that initially formed in one artery can break off and travel to arteries within almost any organ in the body. A blood clot in an artery in the brain causes a stroke (just like a blood clot in a vein in the brain), and a blood clot in an artery in the heart causes a heart attack. Hormonal contraception also increases the risk of these types of blood clots. In some cases larger strokes are preceded by smaller strokes, called transient ischemic attacks (TIA)—this occurs when a blood vessel is blocked temporarily by a blood clot. The incidence of stroke has increased significantly, especially in young people, from 1995 to 2008.

Symptoms of strokes caused by a blood clot in an artery are similar to those described above for CVT. Early treatment of a stroke results in significantly better outcomes; therefore the American Heart and Stroke Association has developed the following acronym to help people recognize the early warning signs: F.A.S.T.

  • F: Face drooping
  • A: Arm weakness
  • S: Speech difficulty
  • T: Time to call 911.

Warning signs of a heart attack in women include:

  • Chest pain—can feel like uncomfortable pressure, squeezing, fullness or pain in the center of the chest.
  • Pain or discomfort in one or both arms, back, neck, jaw or stomach.
  • Shortness of breath with or without chest discomfort.
  • Nausea, light-headedness, or breaking out in a cold sweat.

It should be noted, that women may experience the signs of a heart attack differently than men and diagnosing heart attacks in women is sometimes more complicated requiring great persistence on the part of the patient and the family. An example of this can be found here.

Other Factors That Increase Risk

An individual’s risk of getting a blood clot depends on a combination of genetic factors, acquired conditions, and environmental/lifestyle factors. Although many women may be familiar with the oft-cited risk factors of being overweight, smoking, and being over age 35, many women might be surprised to realize that some of the seemingly innocuous factors described below, or undiagnosed genetic conditions, can combine to increase the risk substantially.

Genetic Factors

Certain inherited conditions, known as inherited thrombophilias, can increase the risk of developing a blood clot. Many people with these inherited conditions have no signs or symptoms of a blood clotting disorder until an environmental or acquired risk factor or factors comes into the picture (such as a hormonal contraceptive), at which point their risk of developing a blood clot increases substantially. These inherited thrombophilias include antithrombin deficiency, protein C deficiency, protein S deficiency, Prothrombin (factor II) mutation, factor V Leiden mutation and hyperhomocysteinemia (which can be caused by MTHFR mutation). The effect of the increased risks from hormonal contraceptives and inherited thrombophilias is synergistic, meaning the risk is much larger than the risk of the two added together; for example, in hormonal contraceptive users carrying a factor V Leiden mutation, the risk of a blood clot is increased 35 fold. Inherited thrombophilias can be detected by genetic testing, but are not routinely screened for. More information about inherited thrombophilias can be found on the National Blood Clot Alliance website.

Acquired Conditions

The acquired condition that is most commonly associated with an increased risk for blood clotting is an autoimmune condition called anti-phospholipid syndrome (and less commonly anti-cardiolipin antibodies, or anti-B2 glycoprotein 1 antibodies). These antibodies can occur on their own, in the absence of other autoimmune diseases, or they can occur secondary to autoimmune diseases such as lupus. These conditions can cause other symptoms in addition to blood clots, such as miscarriage and migraine. Cancer, especially metastatic cancer, is also a recognized risk factor for thrombosis. Hyperhomocysteinemia can also be an acquired condition due to nutritional deficiencies, some chronic illnesses, and medications. Chronic inflammatory conditions such as Crohn’s disease also increases the risk of blood clots.

Environmental or Lifestyle Factors

Certain lifestyle factors are also known to increase the risk of blood clots, including:

The risk of developing a blood clot also increases with increasing age.

It must be stressed that one does not need to have a genetic or acquired risk factor to develop a blood clot, or even to have a fatal blood clot. Following are just a few of many stories of young, healthy women who were seriously affected or died from blood clots while on hormonal contraception.

These women unfortunately did not realize that their choice of birth control was putting them at increased risk. For these women, knowing that they were at increased risk, and knowing the warning signs of a blood clot, could have saved their lives. That is why we are urging all women to become aware of these warning signs, investigate your personal risk, make smart, informed choices of birth control methods, and seek medical attention immediately if you are experiencing signs of a blood clot.

In Memory

This article was inspired by and written in memory of Karen Langhart, who tragically took her own life four years after her young, healthy, vibrant daughter Erika, died suddenly from bilateral massive pulmonary embolisms caused by the Nuvaring. Since Erika’s death, Karen had worked tirelessly to ensure that other families would not suffer the tragedy that hers did.

Hormones Matter will be covering this important topic in more detail in the coming months, so please follow this website, or follow us on Facebook and Twitter at and @HormonesMatter. If you have experience with contraceptive induced blood clots and would like to contribute a personal story or research article, please consider writing for Hormones Matter.

Image by starline on Freepik